The Science
Behind Ranvier
Ranvier combines four breakthrough technologies to deliver fast, objective insights into mood and brain health:
TasteDX™
A patented taste-based test that screens for depression through sensory markers.
BioDX™
Whole blood assay that predicts Alzheimer’s and Parkinson’s years before symptoms appear.
DigitalDX
Passive behavioural data captured through devices to detect early changes in mental health.
AI Inference Layer
Proprietary engine that fuses multimodal inputs into clear, actionable diagnoses.
These tools eliminate subjectivity from mental health and neurological screening, removing reliance on stigmatised self-report questionnaires, enabling earlier detection, smarter treatment, and measurable outcomes.
TasteDX™
Objective, instant, low-cost screening for depression.
Learn more
BioDX™
Accurate risk factor analyses predicting neurodegeneration.
Learn more
DigitalDX
Digital biomarkers and trend analyses to inform behavioural support.
AI Inference Layer
Machine inference and predictive modelling to deliver agentic interventions.
A proprietary AI Inference Engine that fuses it all into clear, actionable insights.
AI Inference Layer integrates all inputs to generate a real-time diagnostic profile, enabling longitudinal monitoring and tailored intervention strategies.